Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function

Neuro-Oncology

Volumn 18, Issue 12, 2016, Pages 1634-1643

  Vannini, Eleonora ^a   Olimpico, Francesco ^a   Middei, Silvia ^a   Ammassari Teule, Martine ^a   De Graaf, Erik L ^b   McDonnell, Liam ^b   Schmidt, Gudula ^c   Fabbri, Alessia ^d   Fiorentini, Carla ^d   Baroncelli, Laura ^a   Costa, Mario ^e   Caleo, Matteo ^a,e  

^a CNR   (Italy)

^b Mass Spectrometry and Proteomics   (Italy)

^c UNIVERSITY OF FREIBURG   (Germany)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e SCUOLA NORMALE SUPERIORE   (Italy)

Author keywords

Cytotoxic necrotizing factor 1; Dendritic structure; Evoked potentials; Senescence; Visual cortex

Indexed keywords

CYTOTOXIC NECROTIZING FACTOR 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; BACTERIAL TOXIN; ESCHERICHIA COLI PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; RHO GTPASE-ACTIVATING PROTEIN; TRANSCRIPTOME;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CANCER INHIBITION; CELL AGING; CELL FUNCTION; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; ELECTROPHYSIOLOGY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LENGTH; MICROARRAY ANALYSIS; MOUSE; NERVE CELL; NONHUMAN; PROTEIN FUNCTION; PROTEOMICS; PYRAMIDAL NERVE CELL; TRANSCRIPTOMICS; VISUAL EVOKED POTENTIAL; ANIMAL; BRAIN NEOPLASMS; DRUG EFFECTS; GLIOBLASTOMA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BACTERIAL TOXINS; BRAIN NEOPLASMS; CELL AGING; CELL LINE, TUMOR; CEREBRAL CORTEX; ELECTROPHYSIOLOGY; ESCHERICHIA COLI PROTEINS; GLIOBLASTOMA; GTPASE-ACTIVATING PROTEINS; HUMANS; MICE; NEURONS; PROTEOMICS; TRANSCRIPTOME;

EID: 85017138448     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/now114     Document Type: Article

References (34)

1. Johnson DR, O’Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2012; 107(2):359–364.
2. Buckingham SC, Campbell SL, Haas BR, et al. Glutamate release by primary brain tumors induces epileptic activity. Nat Med. 2011; 17(10):1269–1274.
3. Sontheimer H. A role for glutamate in growth and invasion of primary brain tumors. J Neurochem. 2008;105(2):287–295.
4. Brown PD, Jensen AW, Felten SJ, et al. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol. 2006;24(34):5427–5433.
5. Hilverda K, Bosma I, Heimans JJ, et al. Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings. J Neurooncol. 2010;97(1):89–94.
6. Marcus HJ, Carpenter KL, Price SJ, et al. In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines. J Neurooncol. 2010;97(1):11–23.
7. Pallud J, Le Van Quyen M, Bielle F, et al. Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci Transl Med. 2014;6(244):244ra289.
8. Venkatesh HS, Johung TB, Caretti V, et al. Neuronal activity promotes glioma growth through neuroligin-3 secretion. Cell. 2015;161(4):803–816.
9. Vannini E, Restani L, Pietrasanta M, et al. Altered sensory processing and dendritic remodeling in hyperexcitable visual cortical networks. Brain Struct Funct. 2015.
10. Vannini E, Panighini A, Cerri C, et al. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model. BMC Cancer. 2014;14:449.
11. Diana G, Valentini G, Travaglione S, et al. Enhancement of learning and memory after activation of cerebral Rho GTPases. Proc Natl Acad Sci U S A. 2007;104(2):636–641.
12. Cerri C, Fabbri A, Vannini E, et al. Activation of Rho GTPases triggers structural remodeling and functional plasticity in the adult rat visual cortex. J Neurosci. 2011;31(42):15163–15172.
13. Flatau G, Lemichez E, Gauthier M, et al. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature. 1997; 387(6634):729–733.
14. Schmidt G, Sehr P, Wilm M, et al. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature. 1997; 387(6634):725–729.
15. de Graaf EL, Kaplon J, Mohammed S, et al. Signal transduction reaction monitoring deciphers site-specific PI3K-mTOR/MAPK pathway dynamics in oncogene-induced senescence. J Proteome Res. 2015;14(7):2906–2914.
16. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008; 26(12):1367–1372.
17. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
18. Restani L, Cerri C, Pietrasanta M, et al. Functional masking of deprived eye responses by callosal input during ocular dominance plasticity. Neuron. 2009;64(5):707–718.
19. Feng G, Mellor RH, Bernstein M, et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron. 2000;28(1):41–51.
20. Wang J, Duncan D, Shi Z, et al. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 2013;41: (Web Server issue)W77–W83.
21. Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005;33:(Web Server issue)W741–W748.
22. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–13.
23. Miraglia AG, Travaglione S, Meschini S, et al. Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2. Mol Biol Cell. 2007;18(7): 2735–2744.
24. Pancrazi L, Di Benedetto G, Colombaioni L, et al. Foxg1 localizes to mitochondria and coordinates cell differentiation and bioenergetics. Proc Natl Acad Sci U S A. 2015;112(45): 13910–13915.
25. Travaglione S, Loizzo S, Rizza T, et al. Enhancement of mitochondrial ATP production by the Escherichia coli cytotoxic necrotizing factor 1. FEBS J. 2014;281(15):3473–3488.
26. Piteau M, Papatheodorou P, Schwan C, et al. Lu/BCAM adhesion glycoprotein is a receptor for Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1). PLoS Pathog. 2014;10(1):e1003884.
27. Augspach A, List JH, Wolf P, et al. Activation of RhoA,B,C by yersinia cytotoxic necrotizing factor (CNFy) induces apoptosis in LNCaP prostate cancer cells. Toxins (Basel). 2013;5(11):2241–2257.
28. Loizzo S, Rimondini R, Travaglione S, et al. CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer’s disease. PLoS One. 2013;8(5):e65898.
29. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, et al. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009;4(12):1798–1806.
30. Armstrong TS, Grant R, Gilbert MR, et al. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro Oncol. 2016;18(6):779–789.
31. Campbell SL, Robel S, Cuddapah VA, et al. GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy. Glia. 2015;63(1):23–36.
32. Liu BH, Li P, Sun YJ, et al. Intervening inhibition underlies simple-cell receptive field structure in visual cortex. Nat Neurosci. 2010;13(1):89–96.
33. Dumas TC, Sapolsky RM. Gene therapy against neurological insults: sparing neurons versus sparing function. Trends Neurosci. 2001;24(12):695–700.
34. Caleo M, Medini P, von Bartheld CS, et al. Provision of brain-derived neurotrophic factor via anterograde transport from the eye preserves the physiological responses of axotomized geniculate neurons. J Neurosci. 2003;23(1):287–296.